Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.53438
Abstract: This cohort study examines the association between approval characteristics, clinical benefit, and prices of cancer drugs recommended for reimbursement by the Canadian Agency for Drug and Technology in Health. read more here.
Keywords: assessment price; price clinical; clinical benefit; cancer drugs ... See more keywords